Preparation and evaluation of a new erythromycin derivative - Erythromycin taurate

Acta Pharmaceutica

Volumn 54, Issue 3, 2004, Pages 231-242

  Manna, Prabal Kumar ^a   Kumaran, Venugopal ^a   Mohanta, Guru Prasad ^a   Manavalan, Rajappan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antimicrobial potency in vitro; Erythromycin taurate; Pharmacokinetic parameters in vivo

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; ERYTHROMYCIN TAURATE; ESSENTIAL AMINO ACID; TAURIC ACID; TAURINE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL INFECTION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUBILITY; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROSCOPY; KLEBSIELLA PNEUMONIAE; LD 50; MALE; MELTING POINT; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; RABBIT; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING;

EID: 6344288663     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. L. P. Garrod, H. P. Lambert and F. O. Grady, Antibiotics and Chemotherapy, Churchill Livingstone Publishers, Edinburgh 1973.
2. A. H. C. Chun and J. A. Seitz, Drug bioavailability information and its utility, J. Am. Pharm. Assoc. 14 (1974) 407-414.
3. A. H. C. Chun and J. A. Seitz, Pharmacokinetics and biological availability of erythromycin, Infection 5 (1977) 14-22.
4. C. E. Mathur, K. C. Austin, C. R. Philpot and P. J. McDonald, Absorption and oral bioavailability of erythromycin, Br. J. Clin. Pharmacol. 12 (1981) 131-140.
5. J. A. Shuraman, Taurine in development, Physiol. Rev. 73 (1993) 119-147.
6. R. J. Huxtable and C. A. Sebring, Cardiovascular actions of taurine, in Sulfur Amino Acids - Biochemical and Clinical Aspects (Eds. K. Kuriyama, R. J. Huxtable and I. Wata), Alan R. Liss Publications, New York 1983, pp. 5-37.
7. E. M. Airaksinen, S. S. Oja and K. M. Marnela, Effect of taurine treatments on epileptic patients, Prog. Clin. Biol. Res. 39 (1980) 157-166.
8. Y. Matsuyama, T. Marita, M. Higuchi and T. Sujii, The effect of taurine administration on patients with acute hepatitis, Prog. Clin. Biol. Res. 125 (1983) 461-468.
9. S. Carasco, R. Codoceo and G. Prieto, Effect of taurine supplements on growth, fat absorption and bile acid on cystic fibrosis, Acta Univ. Carol. 36 (1990) 152-156.
10. S. K. Dutta and S. K. Basu, Preparation of Erythromycin Aldobionate, Indian Pat. No. 142584, 30 July 1977; ref. Chem. Abstr. 85 (1978) 121653a.
11. S. K. Dutta and S. K. Basu, Preparation of Erythromycin Aldobionate, US Pat. 4137397, 30 Jan 1979; ref. Chem. Abstr. 92 (1979) 111271h.
12. Indian Pharmacopoeia, Vol. I, The Controller of Publications, New Delhi, pp. 292-293.
13. J. R. Marsh and P. J Weiss, Solubility of antibiotics in 26 solvents, J. Assoc. Offic. Anal. Chem. 50 (1977) 457-462.
14. D. C. Grove and U. A. Randall, Assay Methods of Antibiotics - A Laboratory Manual, Marcel Dekker, New York (1955).
15. th ed., Churchill Livingstone, Edinburgh 2002, pp. 58-59.
16. OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure (adapted December 17, 2001), Organisation for Economic Co-operation and Development, 2001.
17. P. K. Manna, S. K. Basu, and B. B. Goswami, Studies on erythromycin melibionate - a new water soluble salt of erythromycin, Drug. Dev. Ind. Pharm. 21 (1995) 2097-2107.
18. P. K. Manna and S. K. Basu, Preparation and evaluation of erythromycin fumarate - a new derivative of erythromycin, Drug. Dev. Ind. Pharm. 24 (1998) 879-882.
19. P. K. Manna and S. K. Basu, Studies of erythromycin maltobionate, a new derivative of erythromycin, Drug. Dev. Ind. Pharm. 25 (1999) 391-395.
20. P. G. Welling and W. A. Craig, Pharmacokinetics of intravenous erythromycin, Am. J. Pharm. Sci. 67 (1978) 1057-1058.
21. M. Gibaldi and D. Perrier, Pharmacokinetics, Churchill Livingstone Publications, New York 1983, Vol I, Appendix - 3, pp. 281-284.